DEA (VS) verklaart cannabis als ongevaarlijk, maar weigert de medicinale kracht van cannabis te erkennen……..

Anti-Media bracht afgelopen woensdag het bericht dat de Drug Enforcement Administration (DEA) in de VS cannabis als ongevaarlijk genotsmiddel heeft gekwalificeerd. Sterker nog het gebruik van cannabis geeft een groot aantal voordelen!!

Zo wordt je gelukkig en vrolijk door het gebruik van cannabis, het zorgt voor socialisering, spraakzaamheid en laat de gebruiker beter genieten van muziek en kunst, aldus de DEA rapportage.

‘Uiteraard’ wijst de DEA wel op negatieve effecten die kunnen optreden na het gebruik van cannabis, zoals bronchitis en longemfyseem, terwijl daar bij gebruik van cannabis zonder tabak geen bewijzen voor zijn.

De DEA wil verder niet ingaan op de sterk geneeskrachtige werking van cannabis en producten gemaakt van cannabis, dit alleen omdat cannabis op de nummer 1 lijst voor (verboden/gevaarlijke) drugs staat……. ha! ha! ha! ha! ha! ha! ha!

In het rapport van de DEA ‘Drugs of Abuse’ staat vreemd genoeg niet de harddrug die verreweg de meeste schade toebrengt en dat op meerdere vlakken, alcohol!!

Het valt nog mee dat de DEA ‘zo gunstig rapporteerde’ over cannabis, daar de alcoholindustrie via lobby kapitalen steekt in het verboden houden van o.a. cannabis………

Al met al een mooi artikel van Carey Wedler, ook informatief over andere drugs als MDMA en LSD. Voorts wijst Wedler op de hypocrisie t.a.v. voorschrift medicatie in de rapportage van de DEA, die vooral in de VS voor veel problemen zorgt en een enorm aantal doden veroorzaakt, zoals men het afgelopen jaar een aantal keren heeft gemeld in de reguliere VS media……

The
DEA Just Admitted Weed Has Never Killed Anyone and Causes ‘Happiness’

June
28, 2017 at 4:08 pm

Written
by 
Carey
Wedler

(ANTIMEDIA Op-ed) The
Drug Enforcement Agency just admitted that cannabis has never killed
anyone. Ever. They also acknowledged that the little green plant,
which has been used across 
civilizations for
thousands of years, causes “merriment” and “happiness.” But
they still want to keep it illegal.

The
new 94-page 
report
released this week
 is
entitled “Drugs of Abuse” and is intended to foster a better
understanding of the dangers of drug consumption. “
Education
plays a critical role in preventing substance abuse
,”
the document opens. “
Drugs
of Abuse, A DEA Resource Guide, is designed to be a reliable resource
on the most commonly abused and misused drugs in the United States
.”

While
the report correctly includes seriously dangerous drugs like heroin,
fentanyl, and pharmaceutical opioids, it also includes substances
increasingly proven to be far less harmful than the government would
like its citizens to believe — “drugs” that actually have
medicinal properties. The report fails to acknowledge these benefits
throughout its in-depth explanations.

Nevertheless,
when it comes to cannabis, the DEA is surprisingly honest, at least
in part. Describing the plant for what it is — a “dry,
shredded green/brown mix of flowers, stems, seeds, and leaves

— they note that “[n]o deaths from overdose of marijuana have
been reported.

They
even acknowledge that cannabis use can cause “[m]erriment,
happiness, and even exhilaration at high doses
,” as well as
[d]isinhibition, relaxation, increased sociability, and
talkativeness
.” The illegal, allegedly dangerous substance even
causes — gasp — “[e]nhanced sensory perception, giving rise
to increased appreciation of music, art, and touch
.”

Of
course, the report focuses far more on the “dangerous” effects of
the plant, including bronchitis, emphysema, paranoia, anxiety, panic
attacks, and a litany of other alleged dangers. Despite the fact that
research has found marijuana use has few significant effects on
 lung
health
 —
far less than 
legal tobacco
use
 —
and the fact that mounting evidence shows varieties of cannabis like
CBD (cannabidiol) can help treat 
anxiety and
other 
mental
health ailments
,
the DEA displays no such nuance in their explanations, instead
appearing to base their assessment of safety on the 
legality of
the drug.

For
example, though they claim cannabis can cause nausea, they go on to
explain in the very same section that “Marinol, a synthetic
version of THC, the active ingredient found in the marijuana plant,
can be prescribed for the control of nausea and vomiting caused by
chemotherapeutic agents used in the treatment of cancer and to
stimulate appetite in AIDS patients.

Wait,
what?

Indeed,
though cannabis is indisputably a form of medicine, whether for
nausea, anxiety, Parkinson’s disease, Crohn’s disease, chronic
pain, or countless other disorders, the DEA insists that because it
is a Schedule I drug, it has no medicinal value.

The
same pattern emerges with psychedelic drugs, which the federal
government also claims have no medicinal value despite increasing
evidence that MDMA can help treat PTSD (the FDA itself has
authorized 
research into
the drug’s potential for helping those who suffer with it) and that
psychedelic 
mushrooms and LSD can
help treat depression.

None
of this is acknowledged in the report. Instead, myths that they are
addictive and dangerous abound.

Further,
conspicuously absent from “Drugs of Abuse” is one of the most
dangerous, addictive, and harmful drugs in the history of mankind:
alcohol. 
According to
the government, itself, alcohol is 
responsible for
88,000 deaths per year in the United States, and 15.1 million
Americans suffer from “Alcohol Use Disorder.” But the substance
remains legal. Interestingly, the 
alcohol
industry
 remains
one of the largest anti-marijuana legalization lobbies.

The
agency’s dogmatic adherence to arbitrary law is the reason why
alcohol is excluded from this comprehensive attempt to educate
Americans on the dangers of substance abuse. As the report explains
in the introduction, “There are also a number of substances that
are abused but not regulated under the CSA [Controlled Substance
Act]. Alcohol and tobacco, for example, are specifically exempt from
control by the CSA,
” and are therefore not included in “Drugs
of Abuse.”

Other
hypocrisies abound. For example, the report lists benzodiazepines
like Xanax as potentially addictive drugs, noting that those who use
benzodiazepines
to treat anxiety are likely to be physically dependent on that
medication.” 
But
according to the CSA, on which they base their entire drug
enforcement agenda, drugs like Xanax 
have “low
potential for abuse and low risk of dependence
.”
This is patently false, as 13.5 million Americans are dependent
on
 drugs
like Xanax
,
overdoses are on the rise, and side effects of quitting the
drug 
include heart
palpitations, panic attacks, and seizures in extreme cases. Yet the
DEA, which enforces the CSA, admits in its own report that Xanax
causes physical dependency.

Ultimately,
while the DEA admits cannabis has never caused deaths and can make
for a good deal of “merriment” and “exhilaration,” the most
telling aspect of the report is the futility of banning drugs in the
first place. The exclusion of alcohol from this report — except the
countless instances where it acknowledges that the drug can
intensify 
other drug
experiences — shows the federal government’s tirades against
“drugs” have nothing to do with keeping people safe. Prohibition
in the 1920s 
proved
this
,
and the ongoing failure that is the “War on Drugs” continues to
prove it today.

Even
abusing the dangers of cannabis, MDMA, and other drugs the DEA lists
in its report are accurate, the fact remains that other legal drugs
pose just as many, if not more dangers, and individuals should be
free to take risks with their own health, just as they are with
alcohol and tobacco.

Legal
or not, people will find ways to use drugs, and while the authors of
“Drugs of Abuse” likely have good intentions, their efforts are
futile in their lack of honesty about many of the substances listed
and their continued belief that more government and throwing
non-violent people in cages will solve the deeply-rooted problem of
addiction.

Opinion
/
 Creative
Commons
 / Anti-Media / Report
a typo

Cannabis claim door grote farmaceut in voorbereiding (……) en cannabisolie uit Nederland

BNR had gistermorgen Jos Everts, apotheker van CannabisZorg uit Rosmalen in de uitzending (rond 11.35 u.). Volgens BNR heeft Everts de eerste cannabisapotheek in Europa…… ‘Niet helemaal waar’, de Transvaal Apotheek in Den Haag maakt en verkoopt al langer cannabisolie. Ach ja, BNR, als Radio1 tuk op sensatie moet u maar denken……

Cannabiszorg – Medicinale Cannabisolie

Everts sprak over flessen met cannabisolie, de inhoud? 10 milliliter….. ha! ha! ha! ha! ha! ha! ha! Eén van de presentatoren, kwal Laseur zo te horen, vroeg Everts niet naar de prijs van zijn product, maar die is niet misselijk: Voor een ‘fles’ van 10 milliliter met amper nog werkzame stof, vraagt Everts maar liefst € 29,50!! Een ‘fles’ met zo te zien de sterkst werkzame stof, alweer 10 ml, kost (houdt u vast): € 75,– ha! ha! ha! ha! ha! ha! ha! Ja, dat is lekker binnenlopen, zal Everts gedacht hebben.

In tempo vertelde Everts dat hij er alles aan doet om binnen de wettelijke grenzen van de Opiumwet te handelen…… Te zot voor woorden, dat dit onder de Opiumwet valt, ‘maar goed…….’

PGMCG.NL

Overigens zijn er veel verhalen over de sterke medicinale werking van cannabisolie te vinden op het internet. Men zou er kanker mee tot staan hebben gekregen en in een beperkt aantal gevallen zelfs hebben genezen.

Anti-Media bracht afgelopen zondag een bericht over cannabis, waarin wordt beschreven dat wetenschappers in de VS cannabis eindelijk zien als medicijn, ook tegen een vorm van epilepsie bij kinderen. De FDA houdt het gebruik nog tegen, behalve voor een grote farmaceut, GW Pharmaceuticals, die een eigen gepatenteerde stof Epidiolex heeft ontwikkeld

De houding van de FDA heeft in de VS de vrees doen ontstaan, dat GW Pharmaceuticals straks de cannabisplant zal patenteren, de cannabisplant is al meer dan drieduizend jaar bekend als een geneeskrachtige plant……. Via de vermaledijde ‘vrijhandelsverdragen’ CETA en TTIP (dat de EU weer uit de kast wil halen), zal de plant dan ook hier geclaimd worden door GW Pharmaceuticals…………

Mainstream
Science Finally Accepts Cannabis as Medicine — There’s Just One
Problem

May
27, 2017 at 12:52 pm

Written
by 
Carey
Wedler

(ANTIMEDIA) Mainstream
science is finally 
starting to accept what
countless parents have known for years: cannabis treats childhood
epilepsy.

According
to a new 
study published
this week in the 
New
England Journal of Medicine
,
cannabidiol (CBD) has been scientifically demonstrated to treats
Dravet syndrome, a rare seizure disorder. This study is reportedly
the first of its kind to demonstrate CBD’s potential to treat
epilepsy in children in a clinical setting.

We
now have solid, rigorous scientific evidence that in this specific
syndrome, cannabidiol is effective at reducing seizures,”
 said
Dr. Orrin Devinsky, a neurologist at New York University Langone
Medical Center and one of the authors of the new study, 
PBS reported.

For
years, anecdotal evidence has shown CBD’s ability to reduce
seizures. Countless epileptic children have benefitted from the
non-psychoactive substance, as have adults who suffer from conditions
like 
Parkinson’s
disease
 and anxiety.

PBS summarized
the study:

For
the trial, researchers enrolled 120 children from 2 to 18 years old
with Dravet syndrome, a rare genetic form of epilepsy that kills up
to 20 percent of patients by the time they are 20. There are no drugs
approved specifically for Dravet.

During
the study, the patients stayed on their normal treatment regimen, and
half of them also received cannabidiol while the remainder were given
a placebo. Over a 14-week treatment period, the median number of
convulsive seizures in the cannabidiol group decreased from 12.4 to
5.9 per month; for the placebo group, the number went from 14.9 to
14.1.”

Though
some participants experienced side effects like fatigue and nausea —
and researchers caution more study is needed — the positive effects
of CBD were statistically significant.

According to
Dr. Samuel Berkovic of the University of Melbourne,
who 
acknowledged the
need for more research, the study represents “
the
beginning of solid evidence for the use of cannabinoids in epilepsy
.”

While
the findings vindicate the experiences of an increasing number of
people and support mounting 
research documenting
CBD’s potential, there is just one problem: the study was sponsored
by GW Pharmaceuticals, which backed the study as part of its Phase 3
approval process with the FDA (previous trials had highlighted the
medical benefits, but this installment of the study is more concrete
and has been peer-reviewed).

The
hypocrisy on the part of the Food and Drug Administration is stark;
though the agency has repeatedly 
refused to
fully acknowledge the medical promise of cannabis, it has allowed
progress for the pharma giant, which brands its version of the
substance Epidiolex.

The
FDA has otherwise denied this potential despite 
volumes of
studies on cannabis — including CBD — showing the medicinal
benefits not just for epilepsy, but a host of ailments. It claims
more research is necessary, but in previously recommending that
cannabis remain a Schedule I drug, it has helped 
hinder further
research — except, apparently, by pharmaceutical companies.

By
empowering and elevating GW Pharmaceuticals, the FDA is ultimately
paving the way for a Big Pharma monopoly on the thousands-year-old
plant and, specifically, cannabidiol, which is one of the most
promising cannabinoids for medical use.

Further,
around the country, GW and its American subsidiary, Greenwich
Biosciences, have been 
hedging
their bets
 in
state legislatures, lobbying lawmakers to ensure monopolies over
cannabidiol as acceptance of medical marijuana continues to grow and
legalization becomes increasingly inevitable.

Regardless
of the establishment undertones plaguing the new research, however,
the findings are indisputably positive. As PBS further
summarized:

In
the cannabidiol group, 43 percent of patients had their number of
seizures cut in half or more, compared with 27 percent in the placebo
group. And 5 percent of patients taking cannabidiol saw their
seizures disappear, compared with none in the placebo group
.”

Someone
should inform DEA Chief Chuck Rosenberg, who 
continues to
reiterate his longstanding, false belief that  “
marijuana
is not medicine.

He has also 
said:

What
really bothers me is the notion that marijuana is also medicinal —
because it’s not.

He
insinuated it was a “joke.”

Incidentally,
his fact-devoid statements are likely 
bolstered by
the recommendations of the FDA — the same one currently in the
process of approving GW’s Epidiolex for medical use.

Creative
Commons
 Anti-Media Report
a typo

===================================

Klik voor meer berichten n.a.v. het bovenstaande, op één van de labels, die u hieronder terug kan vinden, dit geldt (nog) niet voor de labels: CBD, O. Devinsky, Epidiolex, J. Everts, FDA, C. Rosenberg en Transvaal Apotheek.

Mijn excuus voor de belabberde weergave.